128 related articles for article (PubMed ID: 4591440)
41. Murine leukemia virus: restriction in fused permissive and nonpermissive cells.
Tennant RW; Richter CB
Science; 1972 Nov; 178(4060):516-8. PubMed ID: 4342878
[TBL] [Abstract][Full Text] [Related]
42. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.
Aoki T; Stephenson JR; Aaronson SA
Proc Natl Acad Sci U S A; 1973 Mar; 70(3):742-6. PubMed ID: 4351802
[TBL] [Abstract][Full Text] [Related]
43. Variations in expression of surface antigens on cultured cells.
Cikes M
Ann N Y Acad Sci; 1971 Jun; 177():190-200. PubMed ID: 4945663
[No Abstract] [Full Text] [Related]
44. Antibody-induced redistribution of surface antigen is independent of the amount of antigen and the cell cycle position.
Killander D; Yefenof E; Klein E
Exp Cell Res; 1974 Dec; 89(2):413-5. PubMed ID: 4616837
[No Abstract] [Full Text] [Related]
45. Immunochemical characterization of tumor-associated surface antigens on a Moloney leukemia virus-lymphoma, MBL-2.
Ng AK; McIntire KR; Suzuki S; Aoki T; Herberman RB
Int J Cancer; 1979 Oct; 24(4):504-12. PubMed ID: 528073
[TBL] [Abstract][Full Text] [Related]
46. Antigenic deletion and malignant enhancement induced in lymphoma cells by passage through X-irradiated hosts.
Joachim HL; Pearse A; Keller SE
Nature; 1977 Jan; 265(5589):55-7. PubMed ID: 189199
[No Abstract] [Full Text] [Related]
47. Studies on the relations between virus release and cellular immunosensitivity in Moloney lymphomas.
Fenyö EM; Biberfeld P; Klein E
J Natl Cancer Inst; 1969 May; 42(5):837-55. PubMed ID: 5785011
[No Abstract] [Full Text] [Related]
48. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
[No Abstract] [Full Text] [Related]
49. Comparative immunofluorescence of murine leukemia virus-derived membrane-associated antigens.
Satake M; Luftig RB
Virology; 1983 Jan; 124(2):259-73. PubMed ID: 6337447
[TBL] [Abstract][Full Text] [Related]
50. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
Lamon EW; Skurzak HM; Klein E; Wigzell H
J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
[No Abstract] [Full Text] [Related]
51. Comparative studies of feline and human leukemia by mixed hemadsorption reaction.
Maruyama K; Dmochowski L; Rickard CG
Bibl Haematol; 1970; (36):355-67. PubMed ID: 4950967
[No Abstract] [Full Text] [Related]
52. Further studeis on mouse sarcoma virus (Moloney) replication in human cells. Partial host range shift of progeny virus.
Bernard C; Chuat JC; Laprevotte I; Boiron M
Int J Cancer; 1972 Nov; 10(3):518-26. PubMed ID: 4128686
[No Abstract] [Full Text] [Related]
53. Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels.
Troy FA; Fenyö EM; Klein G
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5270-4. PubMed ID: 74831
[TBL] [Abstract][Full Text] [Related]
54. In vivo immune selection of a Moloney murine leukemia virus-induced tumor results in the loss of viral- but not tumor-associated antigens.
Jiang D; Flyer DC
J Immunol; 1990 Nov; 145(10):3502-6. PubMed ID: 1700012
[TBL] [Abstract][Full Text] [Related]
55. Immunogenic properties of a nonproducer malignant tumor induced by murine sarcoma virus.
Law LW; Chang KS; Ting RC
Proc Soc Exp Biol Med; 1976 Sep; 152(4):585-8. PubMed ID: 967890
[TBL] [Abstract][Full Text] [Related]
56. Antigenic analysis of transformed and nontransformed cells from human neoplasms.
Maruyama K; Dmochowski L
Prog Exp Tumor Res; 1974; 19():253-69. PubMed ID: 4373782
[No Abstract] [Full Text] [Related]
57. A serologic comparison of Moloney lymphoma cell surface and Moloney oncornavirus antigens.
Humphrey D; Tsukamoto-Adey A; Witte OM; Fox R; Jerabek L; Weissman IL
J Immunol; 1979 Jul; 123(1):412-8. PubMed ID: 87479
[TBL] [Abstract][Full Text] [Related]
58. Lack of distinctive surface antigen on cells transformed by murine sarcoma virus.
Strouk V; Grundner G; Fenyö EM; Lamon E; Skurzak H; Klein G
J Exp Med; 1972 Aug; 136(2):344-52. PubMed ID: 5043415
[TBL] [Abstract][Full Text] [Related]
59. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
McCoy JL; Ting RC; Morton DL; Law LW
J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
[No Abstract] [Full Text] [Related]
60. Separation of the Moloney leukemia virus-determined cell surface antigen (MCSA) from known virion proteins associated with the cell membrane.
Siegert W; Fenyö EM; Klein G
Int J Cancer; 1977 Jul; 20(1):75-82. PubMed ID: 71277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
